Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2017 Apr;62(4):465-471.
doi: 10.1038/jhg.2016.151. Epub 2016 Dec 22.

Kaufman oculo-cerebro-facial syndrome in a child with small and absent terminal phalanges and absent nails

Ariana Kariminejad  1 , Norbert Fonya Ajeawung  2 , Bita Bozorgmehr  1 , Alexandre Dionne-Laporte  3 , Sirinart Molidperee  2 , Kimia Najafi  1 , Richard A Gibbs  4 , Brendan H Lee  5 , Raoul C Hennekam  6 , Philippe M Campeau  2   7
Affiliations
Case Reports

Kaufman oculo-cerebro-facial syndrome in a child with small and absent terminal phalanges and absent nails

Ariana Kariminejad et al. J Hum Genet. 2017 Apr.

Abstract

Kaufman oculo-cerebro-facial syndrome (KOS) is caused by recessive UBE3B mutations and presents with microcephaly, ocular abnormalities, distinctive facial morphology, low cholesterol levels and intellectual disability. We describe a child with microcephaly, brachycephaly, hearing loss, ptosis, blepharophimosis, hypertelorism, cleft palate, multiple renal cysts, absent nails, small or absent terminal phalanges, absent speech and intellectual disability. Syndromes that were initially considered include DOORS syndrome, Coffin-Siris syndrome and Dubowitz syndrome. Clinical investigations coupled with karyotype analysis, array-comparative genomic hybridization, exome and Sanger sequencing were performed to characterize the condition in this child. Sanger sequencing was negative for the DOORS syndrome gene TBC1D24 but exome sequencing identified a homozygous deletion in UBE3B (NM_183415:c.3139_3141del, p.1047_1047del) located within the terminal portion of the HECT domain. This finding coupled with the presence of characteristic features such as brachycephaly, ptosis, blepharophimosis, hypertelorism, short palpebral fissures, cleft palate and developmental delay allowed us to make a diagnosis of KOS. In conclusion, our findings highlight the importance of considering KOS as a differential diagnosis for patients under evaluation for DOORS syndrome and expand the phenotype of KOS to include small or absent terminal phalanges, nails, and the presence of hallux varus and multicystic dysplastic kidneys.

PubMed Disclaimer

Conflict of interest statement

Authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Individual 1 and 2. (a) Individual 1 at 9 months, (b) frontal view of individual 2 at age ten, (c) individual 2 at age 16 years, (d) lateral view of individual 2 at 16 years, (e) note the absent terminal phalanx and nail of the fifth finger of left hand and terminal hypoplasia of other fingers, (f) hallux valgus developed after surgery to repair severe hallux varus.
Figure 2
Figure 2
X-rays of left hand and foot. (a) Note hypoplasia of terminal phalanges and absence of terminal phalanx of fifth finger. (b) Note severe hallux varus before surgery.
Figure 3
Figure 3
Sanger sequencing analysis and alignment of a segment of UBE3B HECT domain. (a) Sanger sequencing demonstrating heterozygous mutation in parents and homozygous deletion in proband. (b) Conservation of amino acids that are in close proximity to the active site of UBE3B HECT domain, including lys1047.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

  • Alternative genomic diagnoses for individuals with a clinical diagnosis of Dubowitz syndrome.
    Dyment DA, O'Donnell-Luria A, Agrawal PB, Coban Akdemir Z, Aleck KA, Antaki D, Al Sharhan H, Au PB, Aydin H, Beggs AH, Bilguvar K, Boerwinkle E, Brand H, Brownstein CA, Buyske S, Chodirker B, Choi J, Chudley AE, Clericuzio CL, Cox GF, Curry C, de Boer E, de Vries BBA, Dunn K, Dutmer CM, England EM, Fahrner JA, Geckinli BB, Genetti CA, Gezdirici A, Gibson WT, Gleeson JG, Greenberg CR, Hall A, Hamosh A, Hartley T, Jhangiani SN, Karaca E, Kernohan K, Lauzon JL, Lewis MES, Lowry RB, López-Giráldez F, Matise TC, McEvoy-Venneri J, McInnes B, Mhanni A, Garcia Minaur S, Moilanen J, Nguyen A, Nowaczyk MJM, Posey JE, Õunap K, Pehlivan D, Pajusalu S, Penney LS, Poterba T, Prontera P, Doriqui MJR, Sawyer SL, Sobreira N, Stanley V, Torun D, Wargowski D, Witmer PD, Wong I, Xing J, Zaki MS, Zhang Y; Care4Rare Consortium; Centers for Mendelian Genomics; Boycott KM, Bamshad MJ, Nickerson DA, Blue EE, Innes AM. Dyment DA, et al. Am J Med Genet A. 2021 Jan;185(1):119-133. doi: 10.1002/ajmg.a.61926. Epub 2020 Oct 24. Am J Med Genet A. 2021. PMID: 33098347 Free PMC article.
  • UBE3B promotes breast cancer progression by antagonizing HIF-2α degradation.
    Wang Y, Liu X, Wang M, Wang Y, Wang S, Jin L, Liu M, Zhou J, Chen Y. Wang Y, et al. Oncogene. 2023 Nov;42(46):3394-3406. doi: 10.1038/s41388-023-02842-z. Epub 2023 Oct 2. Oncogene. 2023. PMID: 37783786
  • A combined genome-wide association and molecular study of age-related hearing loss in H. sapiens.
    Liu W, Johansson Å, Rask-Andersen H, Rask-Andersen M. Liu W, et al. BMC Med. 2021 Dec 1;19(1):302. doi: 10.1186/s12916-021-02169-0. BMC Med. 2021. PMID: 34847940 Free PMC article.
  • VHL suppresses UBE3B-mediated breast tumor growth and metastasis.
    Wang S, Li H, Liu X, Yin T, Li T, Zheng M, Liu M, Meng X, Zhou J, Wang Y, Chen Y. Wang S, et al. Cell Death Dis. 2024 Jun 24;15(6):446. doi: 10.1038/s41419-024-06844-x. Cell Death Dis. 2024. PMID: 38914543 Free PMC article.
  • The ubiquitin ligase UBE3B, disrupted in intellectual disability and absent speech, regulates metabolic pathways by targeting BCKDK.
    Cheon S, Kaur K, Nijem N, Tuncay IO, Kumar P, Dean M, Juusola J, Guillen-Sacoto MJ, Bedoukian E, Ierardi-Curto L, Kaplan P, Schaefer GB, Mishra P, Chahrour MH. Cheon S, et al. Proc Natl Acad Sci U S A. 2019 Feb 26;116(9):3662-3667. doi: 10.1073/pnas.1818751116. Epub 2019 Feb 11. Proc Natl Acad Sci U S A. 2019. PMID: 30808755 Free PMC article.

References

    1. Kaufman RL, Rimoin DL, Prensky AL, Sly WS. An oculocerebrofacial syndrome. Birth defects original article series. 1971;7:135–138. - PubMed
    1. Basel-Vanagaite L, Dallapiccola B, Ramirez-Solis R, Segref A, Thiele H, Edwards A, et al. Deficiency for the ubiquitin ligase UBE3B in a blepharophimosis-ptosis-intellectual-disability syndrome. American journal of human genetics. 2012;91:998–1010. - PMC - PubMed
    1. Basel-Vanagaite L, Yilmaz R, Tang S, Reuter MS, Rahner N, Grange DK, et al. Expanding the clinical and mutational spectrum of Kaufman oculocerebrofacial syndrome with biallelic UBE3B mutations. Human genetics. 2014;133:939–949. - PubMed
    1. Flex E, Ciolfi A, Caputo V, Fodale V, Leoni C, Melis D, et al. Loss of function of the E3 ubiquitin-protein ligase UBE3B causes Kaufman oculocerebrofacial syndrome. Journal of medical genetics. 2013;50:493–499. - PMC - PubMed
    1. Pedurupillay CR, Baroy T, Holmgren A, Blomhoff A, Vigeland MD, Sheng Y, et al. Kaufman oculocerebrofacial syndrome in sisters with novel compound heterozygous mutation in UBE3B. American journal of medical genetics. Part A. 2015;167A:657–663. - PubMed

Publication types

MeSH terms

Supplementary concepts

LinkOut - more resources